Viewing Study NCT06029257


Ignite Creation Date: 2025-12-24 @ 6:47 PM
Ignite Modification Date: 2026-01-01 @ 4:59 PM
Study NCT ID: NCT06029257
Status: RECRUITING
Last Update Posted: 2025-01-29
First Post: 2023-09-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Tildrakizumab in the Treatment of Genital Psoriasis (CZATCH-Genital-PsO)
Sponsor: Almirall, S.A.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module